Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypermutability and silent mutations in human carcinogenesis.

B S Strauss1

  • 1Department of Molecular Genetics and Cell Biology, The University of Chicago, 920 East 58th Street, Chicago, IL, 60637, USA.

Seminars in Cancer Biology
|April 7, 1999
PubMed
Summary

Silent mutations, which don't change amino acids, reveal that tumors are hypermutable. This finding suggests a mutation frequency significantly higher than normal tissues, impacting cancer research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

STUDIES ON THE EFFECT OF CERTAIN MACROMOLECULAR SUBSTANCES ON THE RESPIRATORY ACTIVITY OF THE LEUCOCYTES OF PERIPHERAL BLOOD.

The Journal of experimental medicine·2009
Same author

Role in tumorigenesis of silent mutations in the TP53 gene.

Mutation research·2000
Same author

Role of the dinB gene product in spontaneous mutation in Escherichia coli with an impaired replicative polymerase.

Journal of bacteriology·2000
Same author

The stability of the genome and the genetic instability of tumors.

Perspectives in biology and medicine·2000
Same author

Frameshift mutation, microsatellites and mismatch repair.

Mutation research·1999
Same author

Our senior partner isn't retired. He's "rehired".

Medical economics·1999

Area of Science:

  • Genetics
  • Molecular Biology
  • Cancer Research

Background:

  • Silent or synonymous mutations are DNA changes that do not alter the resulting amino acid sequence.
  • These mutations constitute about 4% of TP53 mutations within a large dataset.
  • Silent mutations are valuable for estimating unbiased mutation frequencies as they lack selective advantages.

Purpose of the Study:

  • To determine the mutation frequency in tumors using silent mutations.
  • To assess if tumors exhibit a higher mutation rate compared to normal tissues.
  • To explore the concept of tumor hypermutability and supermutability.

Main Methods:

  • Analysis of a database containing nearly 10,000 TP53 mutations.
  • Identification and quantification of silent (synonymous) nucleotide changes.

Related Experiment Videos

  • Comparison of mutation frequencies between tumor and normal tissues (implied).

    • Main Results:

    • Silent TP53 mutations represent approximately 4% of all identified mutations.
    • The observed frequency of silent mutations in tumors is at least 100 times higher than expected for normal tissue.
    • This suggests that tumors are hypermutable, with some potentially being 'supermutable.'

    Conclusions:

    • Tumors exhibit a significantly elevated mutation rate, classifying them as hypermutable.
    • The high frequency of silent mutations provides evidence for increased genomic instability in cancerous cells.
    • Certain tumor types may possess exceptionally high mutation rates, akin to those in immune system development.